Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Medical Officer
-
Stock Symbol
-
STOK on Nasdaq
Barry Ticho - trading volume in the past year for Stoke Therapeutics, Inc.
Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
60.6K |
$501K |
$8.27 |
Mar 19, 2025 |
Direct |
|
|
Restricted Stock Units |
43K |
$356K |
$8.27 |
Mar 20, 2025 |
Direct |
Common Stock |
|
Restricted Stock Unit (RSU) |
12K |
$145K |
$12.07 |
Dec 1, 2024 |
Direct |
Common Stock |
|
Performance Stock Units |
10K |
$121K |
$12.07 |
Dec 3, 2024 |
Direct |
Common Stock |
|
Employee Stock Option (Right to Buy) |
64K |
|
|
Mar 20, 2025 |
Direct |
Common Stock |
|
Stock Option (Right to Buy) |
0 |
|
|
Dec 2, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.